The Past, Present, and Future of Lupus Treatments
Mary Crow, MD, and Christele Felix, a patient with lupus, each provide their perspectives on the recent FDA approval of anifrolumab for SLE treatment.
Rheum Advisor on Air
All Episodes
COVID-19 & Rheumatic Disease: Are We in It for the Long Haul?
In this episode, Swati Deshmukh, MD, talks about the postacute symptoms of COVID-19, including musculoskeletal complications, among “COVID long haulers”, with a focus on patients with rheumatologic disease.
EULAR 2021 Series
The Breath-Taking Lungs and Scleroderma
Toby Maher, MD, describes the increased prevalence of lung manifestations in scleroderma and the need for routine screening among these patients.
The Dish on Diet and Nutrition in Rheumatic Diseases
In this episode of the EULAR 2021 series, Dr Elena Nikiphorou highlights the role of diet in rheumatic and musculoskeletal diseases and what clinicians should tell their patients in this regard.
DMARDs: What Impact Do They Have on COVID-19 Outcomes in RA?
In this episode of the EULAR 2021 Virtual Congress series, Dr Jeffrey Sparks and Dr Zachary Wallace provide further insight into their study about DMARD use and COVID-19 outcomes in rheumatoid arthritis.
ACR 2020 Series
Uncomplicating the Complicated: Pregnancies in Lupus and APS
Jane Salmon, MD, takes us on a deep dive into identifying and predicting the risk for pregnancy complications in patients with lupus and APS.
Make Rheum for Mental Health in Pediatric Rheumatology
In this episode, we discuss the importance of addressing mental health in the pediatric rheumatology population.
Are We Underdiagnosing Large Vessel Vasculitis?
In this episode, Anisha Dua, MD, gives us a brief insight into the various challenges observed with large vessel vasculitis imaging.
Time for an Update: ACR RA Management Guidelines
In this episode, Stanley Cohen, MD, provides a glimpse into the scope and new updates to the ACR RA treatment guidelines.
A Closer Look at Pegloticase Treatment in Gout
In this episode, we discuss the role of pegloticase treatment in gout, as presented at ACR Convergence 2020.
More Episodes
Beyond Race and Ethnicity: Social Determinants of Health and Disparities in Rheumatology
In the first episode of the ACR Convergence 2021 podcast series, Iris Navarro-Millán, MD, discusses the drivers of health care disparities in rheumatology, including race, ethnicity, and social determinants of health.
Rheum Advisor on Air Podcast: Season 2 Trailer
Season 2 of Rheum Advisor on Air, the official podcast of Rheumatology Advisor, is set to kick off with the ACR Convergence 2021 series, followed by expert perspectives on emerging topics in rheumatology.
Psoriasis and Psoriatic Arthritis: Providing Bidirectional Care
In this episode, dermatologist Joel Gelfand, MD, and rheumatologist Alexis Ogdie, MD, provide deeper insight into the overlap and transition of care between patients with psoriasis and PsA.
More Than Just a Pronoun: Ethics of Sex/Gender Assessment in Pediatrics
Karen Onel, MD, Nayimisha Balmuri, MD, and Jacob Spitznagle, MD, speak with us about the ethics of sex/gender assessment in a pediatric rheumatology population.
The Rise of Big Data Registries in Rheumatology – Part 2
We’re discussing the CARRA registry with Yukiko Kimura, MD, and the COVID-19 Global Rheumatology Alliance with Pedro Machado, MD.
The Rise of Big Data Registries in Rheumatology – Part 1
In this episode, Michael George, MD, talks to us about ArthritisPower, Jeff Greenberg, MD, discusses the work of CorEvitas, and Christie Bartels, MD, provides further insight into the ACR’s RISE Registry.
Mind the (Gender) Gap: Inequities Among Women in Academic Rheum
Shereen Mahmood, MD, and Irene Blanco, MD, provide insight into the gender gap and existing inequities among women in academic rheumatology.
Thank “Gout” It’s Not True: Fictional Depictions in Film and TV
This episode features Nehad Soloman, MD, who discusses the implications of the fictional depictions of gout in film and television and how providers can address this.
Unraveling the Mysteries of Novel, Rare Rheumatic Diseases – Part 2
Peter Grayson, MD, of the NIH tells us the story behind the discovery of the new inflammatory syndrome, VEXAS, and the importance of research at a molecular level in rheumatology.
Rarest of Them All: Ultra-Rare Rheumatic Diseases – Part 1
In this episode, Jonathan Miner, MD, discusses his contributions to the ultra-rare disease space in rheumatology.
Rheuminating About COVID-19: A Rheumatologist’s Perspective
In this episode, we get an insight into the current COVID-19 landscape from a rheumatologist’s perspective.
Harnessing the Microbiome to Understand Rheumatic Diseases
In this episode, we discuss how the the microbiome can play a role in the potential treatment of rheumatic diseases.
Let’s Talk Women’s Health in Rheumatic Diseases
In this episode, we’re highlighting the importance of recognizing and discussing women’s health – from premenstruation through menstruation and pregnancy and menopausal transition – in rheumatology.
Digital Health Technologies: The Future of Rheumatology Care
In this episode, we’re taking a deep dive into the role of digital health technologies in rheumatology care and disease management.
To Switch or Not to Switch: Biosimilars in Rheumatology
In this episode, we get further insight into the current state of biosimilars development and adoption in the United States vs other countries, interchangeability among adult and pediatric patients with rheumatologic conditions, nonmedical switching to biosimilars, and an overview of its potential cost benefits for the US healthcare system.
Into the Eye of the COVID-19 Cytokine Storm
In this episode, we get expert perspectives on the immunopathology and management of the cytokine storm in adult and pediatric patients with COVID-19.
Ethnic and Gender Disparities in Rheumatology Care: A Call to Action
In this episode, we highlight and address the disproportionate burden of rheumatic diseases and COVID-19 in ethnic minorities and the gender disparities observed in rheumatology care.
Telerheumatology: The New Normal? Part 2
In part 2 of this series, we’re getting perspectives from an allopathic and an osteopathic physician specializing in rheumatology on the evolution of telemedicine and what the future may look like for the management of rheumatologic conditions.
Telerheumatology: The New Normal? Part 1
Telemedicine in rheumatology, or telerheumatology, may be the future of diagnosis and treatment in rheumatology. In this 2-part episode series, we’re delving deeper into the world of telerheumatology and asking, “Will this be the new normal?”
How Is COVID-19 Affecting the Health of Rheumatologists?
In this episode, we discuss the effect of the COVID-19 pandemic on the health of rheumatologists and how this may have an impact on delivering patient care.
 | Meghna Rao is a postgraduate in the biological sciences from the University of Leeds, United Kingdom, where she also completed a thesis in enzyme kinetics using electrochemical methods. Meghna was a part of the research team at a biopharmaceutical company in India, after which she transitioned into scientific and medical communications and publishing. In her 10 years of experience as a scientific and medical communicator, Meghna has explored content creation and development on diverse platforms, working with various different organizations in the fields of science, medicine, and health, for audiences both clinical and nonclinical. Meghna is currently the medical editor of Rheumatology Advisor, the host of the medical podcast, Rheum Advisor on Air, and a freelance writer. |
| Stephan Cho, is the Digital Content Editor for Cancer Therapy Advisor and the editor of the Rheum Advisor on Air podcast. |
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Rheum Advisor on Air
Loading... 
Loading...